Evidence map›Paper›PMID 17181157›Full record

ArticleJournal of medicinal chemistry2006

Topomimetics of amphipathic beta-sheet and helix-forming bactericidal peptides neutralize lipopolysaccharide endotoxins.

Xuemei Chen, Ruud P M Dings, Irina Nesmelova, Stefan Debbert, Judith R Haseman, Jacques Maxwell, Thomas R Hoye, Kevin H Mayo

Abstract read
In one paragraph

Article in Journal of medicinal chemistry, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 54 citations in OpenAlex.

  1. Defining a lipophilicity window for the antimicrobial activity of 7-Alkoxy-3-Amino coumarin amphiphiles.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Xuemei ChenDepartment of Chemistry and Biochemistry, University of Minnesota, Minneapolis, MN 55455, USA.
Ruud P M Dings
Irina Nesmelova
Stefan Debbert
Judith R Haseman
Jacques Maxwell
Thomas R Hoye
Kevin H Mayo
University of Minnesota · US

Funding

Vaccines and Therapies Against BotulismU54AI057153 · NIAID · UNIVERSITY OF CHICAGO · PI KAWAOKA, YOSHIHIRO · 2003 to 2013
$87.6M
Peptide Based Antiagiogenic Antitumor AgentR01CA096090 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MAYO, KEVIN H. · 2002 to 2011
$2.7M
NCI NIH HHS R01 CA 096090NCI NIH HHS R01 CA096090NIAID NIH HHS U54 AI 057153NIAID NIH HHS U54 AI057153
6 · The paper itself

Abstract

Release of lipopolysaccharide (LPS) endotoxin from Gram negative bacterial membranes triggers macrophages to produce large quantities of cytokines that can lead to septic shock and eventual death. Agents that bind to and neutralize LPS may provide a means to clinically prevent septic shock upon bacterial infection. Previously, we reported the design of antibacterial helix peptide SC4 and beta-sheet-forming betapep peptides that neutralize LPS in vitro. We hypothesized that the ability of these and other such peptides to neutralize LPS rested in the common denominator of positively charged amphipathic structure. Here, we describe the design and synthesis of nonpeptide, calixarene-based helix/sheet topomimetics that mimic the folded conformations of these peptides in their molecular dimensions, amphipathic surface topology, and compositional properties. From a small library of topomimetics, we identified several compounds that neutralize LPS in the 10-8 M range, making them as effective as bactericidal/permeability increasing protein and polymyxin B. In an endotoxemia mouse model, three of the most in vitro effective topomimetics are shown to be at least partially protective against challenges of LPS from different bacterial species. NMR studies provide mechanistic insight by suggesting the site of molecular interaction between topomimetics and the lipid A component of LPS, with binding being mediated by electrostatic and hydrophobic interactions. This research contributes to the development of pharmaceutical agents against endotoxemia and septic shock.

Indexed as

Molecular MimicryAnimalsAnti-Bacterial AgentsAntimicrobial Cationic PeptidesBlood Bactericidal ActivityBlood ProteinsCalixarenesEndotoxemiaEndotoxinsGram-Negative BacteriaHorseshoe CrabsLipid ALipopolysaccharidesMagnetic Resonance SpectroscopyMaleMembrane ProteinsAnti-Bacterial AgentsAntimicrobial Cationic Peptidesbactericidal permeability increasing proteinBlood ProteinsCalixarenesendotoxin binding proteinsEndotoxinsLipid ALipopolysaccharidesMembrane ProteinsPolymyxin B

Identifiers

PMID17181157
PMCPMC4242098
OpenAlexW2037491376

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.